Interventional Radiology, Drugs & Devices Phillip Leblanc Interventional Radiology, Drugs & Devices Phillip Leblanc

Boston Scientific’s Obsidio Embolic Posts Clean 30-Day Results in Company-Sponsored Registry

A Boston Scientific-sponsored registry of 125 patients at 19 U.S. hospitals reports complete target-vessel occlusion and no rebleeding at 30 days with the Obsidio embolic. The single-arm design, company sponsorship and short follow-up limit what the results can show about the device.

Read More